Print Page   |   Contact Us   |   Sign In   |   Join Today
News & Press: General

Eyes on Washington: Federal Health Care Grant Notification Service

Thursday, February 26, 2015   (0 Comments)
Posted by: TCAA Staff
Share |

Eyes on Washington: Federal Health Care Grant Notification Service

 

Grant Opportunities for February 16, 2015 through February 20, 2015

 

Visit Holland & Knight online

  

New Federal Health Care Grant Opportunities Announced for:

·         Centers for Disease Control and Prevention (CDC)

·         Food and Drug Administration (FDA)

·         Health Resources and Services Administration (HRSA)

·         Substance Abuse and Mental Health Services Administration (SAMHSA)

·         National Institutes of Health (NIH)

 

NON-NIH Funding Opportunity Announcements:

 

CDC: Conducting Public Health Research in Georgia

Funding Opportunity Number: RFA-GH-15-002

The purpose of the cooperative agreement is to support research studies of emerging infectious and chronic diseases in Georgia and the South Caucasus and to strengthen existing epidemiologic and laboratory research capacity at national and district level in Georgia and the South Caucasus region. This funding opportunity was announced on February 20, 2015. The application deadline is March 23, 2015. For more information, please visit CDC's Full Funding Opportunity Announcement.

 

CDC: Institutional Research Collaboration with the Liverpool School of Tropical Medicine

Funding Opportunity Number: RFA-GH-15-006

The purpose of this cooperative agreement is to assist with the development of operational research, surveillance, and monitoring and evaluation activities in sub-Saharan Africa and Asia. Through this funding announcement, the Malaria Branch seeks to fund innovative research projects and evaluation activities with the potential to yield high impact public health findings or strategies that will decrease the overall burden of malaria and increase the health and well-being of the populations. CDC's Malaria Branch is a partner of the Roll Back Malaria (RBM) initiative, a partnership that seeks to support and coordinate global malaria program scale-up, surveillance, and evaluation efforts in malaria endemic countries. This funding opportunity was announced on February 20, 2015. The application deadline is March 23, 2015. For more information, please visit CDC's Full Funding Opportunity Announcement.

 

CDC: Conducting Operational Research to Mitigate Morbidity and Mortality Among Internally Displaced Persons Affected by Emergencies

Funding Opportunity Number: RFA-GH-15-008

This research is needed to identify best methods for (1) determining the population size and vulnerabilities, such as mortality rate, among Among Internally Displaced Persons (IDPs) Affected by Emergencies, (2) determining the specific needs of these IDPs, especially in urban settings, and (3) integrating programs across sectors, such as (a) gender-based violence and protection or mental health services, (b) access to potable water and improved sanitation and impact on nutrition or water-borne diseases, and (c) mental health and primary healthcare services. The programs should be proven to be effective individually so that the synergy of them is what is investigated. This funding opportunity was announced on February 20, 2015. The application deadline is March 23, 2015. For more information, please visit CDC's Full Funding Opportunity Announcement.

 

FDA: Pharmacometric Modeling and Simulation for Long Acting Injectable Products

Funding Opportunity Number: RFA-FD-15-008

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for two modeling  and analysis studies focusing on two areas. The first area of study will focus on physiologically-based pharmacokinetic modeling (PBPK) to relate critical quality attributes to in vivo performance for bioequivalence (BE) evaluation. The second area of study will focus on population pharmacokinetic-pharmacodynamic (PK-PD) modeling and statistical analysis to identify ways to reduce residual variability and identify appropriate PK metrics, enabling BE assessment in parallel BE studies with acceptable sample size. The findings from these studies will help establish scientific and regulatory standards for ensuring therapeutic equivalence of generic LAI products. This funding opportunity was announced on February 17, 2015. The application deadline is April 27, 2015. For more information, please visit FDA's Full Funding Opportunity Announcement.

 

FDA: Dissolution Methods for Long-acting Levonorgestrel Intrauterine System

Funding Opportunity Number: RFA-FD-15-006

There is a lack of compendial or biorelevant in vitro drug release assays for long-acting contraceptive intrauterine systems. This Funding Opportunity Announcement (FOA) solicits studies to investigate dissolution methods, both real time and accelerated conditions, for levonorgestrel intrauterine system (5-year application) and to analyze their capability of detecting manufacturing differences, predicting in vivo performance, and to evaluate method robustness. The results from this study will help the FDA in developing recommendations to determine bioequivalence of generic intrauterine systems. This funding opportunity was announced on February 17, 2015. The application deadline is April 27, 2015. For more information, please visit FDA's Full Funding Opportunity Announcement.

 

FDA: Dissolution Methods for Long-acting Periodontal Drug Products

Funding Opportunity Number: RFA-FD-15-007

There is a lack of compendial or biorelevant in vitro drug release assays for long-acting periodontal dosage forms. These products include biodegradable microspheres, in situ forming implants and matrix tablets. This Funding Opportunity Announcement (FOA) solicits studies to develop a bio-relevant dissolution method for a long-acting periodontal dosage form and to identify the drug product's key physicochemical attributes that affect the drug dissolution behavior and bioavailability. The results from this study will help the FDA in developing recommendations to determine bioequivalence of generic long-acting periodontal drug products. This funding opportunity was announced on February 17, 2015. The application deadline is April 27, 2015. For more information, please visit FDA's Full Funding Opportunity Announcement.

 

HRSA: Autism Intervention Research Network on Physical Health (AIR-P)

Funding Opportunity Number: HRSA-15-092

This cooperative agreement will establish and maintain an interdisciplinary, multicenter research forum for scientific collaboration and infrastructure building to provide national leadership in research designed to improve the physical health and wellbeing of children and adolescents with Autism Spectrum Disorders (ASD) or other developmental disabilities. The AIR-P Network will be one of two HRSA-supported research networks that will provide national leadership in research to advance the evidence base on effective interventions for children and adolescents with ASD and other developmental disabilities, with AIR-P having a focus on addressing physical health and wellbeing. It is expected that the AIR-P Network will collaborate with a program serving vulnerable and underserved populations. Such collaboration will enable the Network to recruit and include these populations including minority and rural communities into Network studies.  Such collaboration should also include the participation of an interdisciplinary cadre of researchers, health and related service providers, and community partners in diverse settings to broaden the scope of the Network. This funding opportunity was announced on February 19, 2015. The application deadline is April 21, 2015. For more information, please visit HRSA's Full Funding Opportunity Announcement.

 

 

 

 

HRSA: Autism Intervention Research Network on Behavioral Health (AIR-B)

Funding Opportunity Number: HRSA-15-091

This cooperative agreement will establish and maintain an interdisciplinary, multicenter research forum for scientific collaboration and infrastructure building to provide national leadership in research designed to improve the behavioral, mental, social, and/or cognitive health and wellbeing of children and adolescents with Autism Spectrum Disorder (ASD) and other developmental disabilities. The AIR-B Network will be one of two HRSA-supported research networks that will provide national leadership in research to advance the evidence base on effective interventions for children and adolescents with ASD and other developmental disabilities, with AIR-B having a focus on addressing behavioral health and wellbeing. It is expected that the AIR-B Network will collaborate with a program serving vulnerable and underserved populations.  Such collaboration will enable the Network to recruit and include these populations including minority and rural communities into Network studies. Such collaboration should also include the participation of an interdisciplinary cadre of researchers, health and related service providers, and community partners in diverse settings to broaden the scope of the Network. This funding opportunity was announced on February 19, 2015. The application deadline is April 21, 2015. For more information, please visit HRSA's Full Funding Opportunity Announcement.

 

SAMHSA: 2015 Campus Suicide Prevention Grant

Funding Opportunity Number: SM-15-008

The purpose of the Campus Suicide Prevention (CSP) program is to facilitate a comprehensive public health approach to prevent suicide in institutions of higher education. The CSP program is designed to assist colleges and universities in building essential capacity and infrastructure to support expanded efforts to promote wellness and help-seeking of all students. Additionally, the CSP program will offer outreach to vulnerable students, including those experiencing substance abuse and mental health problems who are at greater risk for suicide and suicide attempts. The CSP program will support a wide range of program activities and prevention strategies to build and sustain a foundation for mental health promotion, suicide prevention, substance abuse prevention and other prevention activities such as interpersonal violence and by-stander interventions. The CSP program seeks to address behavioral health disparities among racial, ethnic, sexual and gender minorities by encouraging the implementation of strategies to decrease the differences in access, service use and outcomes among the racial and ethnic minority populations served. This funding opportunity was announced on February 19, 2015. The application deadline is April 20, 2015. For more information, please visit HRSA's Full Funding Opportunity Announcement.

 

SAMHSA: Capacity Building Initiative for Substance Abuse and HIV Prevention Services for At-Risk Racial/Ethnic Minority Youth and Young Adults

Funding Opportunity Number: SP-15-005

The purpose of the HIV Capacity Building Initiative (CBI) program is to support grantees in building a solid foundation for delivering and sustaining quality and accessible state of the science substance abuse and HIV prevention services. The CBI program aims to engage community-level domestic public and private non-profit entities, tribes and tribal organizations to prevent and reduce the onset of substance abuse and transmission of HIV/AIDS among at-risk populations, including racial/ethnic minority youth and young adults, ages 13-24. SAMHSA is particularly interested in eliciting the interest of college and university clinics/wellness centers and community-based providers who can provide comprehensive substance abuse and HIV prevention strategies. These strategies must combine education and awareness programs, social marketing campaigns, and HIV and viral hepatitis testing services in non-traditional settings with substance abuse and HIV prevention programming for the population of focus. All grantees must be prepared to serve the community in which they are located. This funding opportunity was announced on February 20, 2015. The application deadline is April 23, 2015. For more information, please visit HRSA's Full Funding Opportunity Announcement.

 

NIH Funding Opportunity Announcements:

 

NIH: BRAIN Initiative - Optimization of Novel Tools and Technologies for Neuroscience Research

Funding Opportunity Number: PAR-15-121

In this Funding Opportunity Announcement (FOA), NIH solicits applications focusing on the optimization of existing and emerging technologies and approaches, including (1) technologies and novel approaches for large scale recording and manipulation of neural activity, at or near cellular resolution, at multiple spatial and/or temporal scales, in any region and throughout the entire depth of the brain, as well as (2) tools to facilitate the detailed analysis of complex circuits and provide insights into cellular interactions that underlie brain function. This FOA is intended for the iterative refinement of emergent technologies and approaches that have already demonstrated their transformative potential through initial proof-of-concept testing, and are appropriate for accelerated development with an end-goal of broad dissemination and incorporation into regular neuroscience practice. This funding opportunity was announced on February 19, 2015. The initial application deadline is April 28, 2015. For more information, please visit HRSA's Full Funding Opportunity Announcement.

 


Association Management Software Powered by YourMembership  ::  Legal